Brigit Biofarmaka Teknologi Tbk. vs Maja Agung Latexindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 7.8K 24h volume), while Maja Agung Latexindo Tbk. trades at Rp68 (market cap 430.74B, 477.2K 24h volume). The key difference: Maja Agung Latexindo Tbk. is far larger — about 2.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Maja Agung Latexindo Tbk. is more actively traded (477.2K versus 7.8K). Which is the better fit depends on your goals.
| OBAT | SURI | |
|---|---|---|
Market Cap | 172.82B | 430.74B |
Volume | 7.8K | 477.2K |
Lot | 78 | 4.77K |
Turnover | 1.96M | 32.55M |
Average Price | 251.82 | 68.22 |
Value | 1.96M | 32.55M |
Indicative Equilibrium Price | 254 | 69 |
Indicative Equilibrium Volume | 100 | 438 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Maja Agung Latexindo Tbk (the Company) was established based on Notarial Deed No. 283 dated October 25, 1988 of Benny Kristianto, S.H., notary in Jakarta. The Company started its commercial operations in 1988.
Read more on SURI →